![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 19086 |
FusionGeneSummary for KMT2A_CBL |
![]() |
Fusion gene information | Fusion gene name: KMT2A_CBL | Fusion gene ID: 19086 | Hgene | Tgene | Gene symbol | KMT2A | CBL | Gene ID | 4297 | 867 |
Gene name | lysine methyltransferase 2A | Cbl proto-oncogene | |
Synonyms | ALL-1|CXXC7|HRX|HTRX1|MLL|MLL1|MLL1A|TRX1|WDSTS | C-CBL|CBL2|FRA11B|NSLL|RNF55 | |
Cytomap | 11q23.3 | 11q23.3 | |
Type of gene | protein-coding | protein-coding | |
Description | histone-lysine N-methyltransferase 2ACXXC-type zinc finger protein 7lysine (K)-specific methyltransferase 2Alysine N-methyltransferase 2Amixed lineage leukemia 1myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)trithorax-like | E3 ubiquitin-protein ligase CBLCas-Br-M (murine) ecotropic retroviral transforming sequenceCbl proto-oncogene, E3 ubiquitin protein ligaseRING finger protein 55RING-type E3 ubiquitin transferase CBLcasitas B-lineage lymphoma proto-oncogenefragile si | |
Modification date | 20180519 | 20180523 | |
UniProtAcc | Q03164 | P22681 | |
Ensembl transtripts involved in fusion gene | ENST00000534358, ENST00000389506, ENST00000354520, ENST00000420751, | ENST00000264033, | |
Fusion gene scores | * DoF score | 31 X 72 X 6=13392 | 3 X 3 X 2=18 |
# samples | 129 | 3 | |
** MAII score | log2(129/13392*10)=-3.37592846223973 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: KMT2A [Title/Abstract] AND CBL [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Oncogene involved fusion gene, in-frame and retained their domain. Tumor suppressor gene involved fusion gene, in-frame but not retained their domain. Tumor suppressor gene involved fusion gene, retained protein feature but frameshift. DDR (DNA damage repair) gene involved fusion gene, in-frame but not retained their domain. Transcription factor involved fusion gene, inframe and retained DNA-binding domain. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | KMT2A | GO:0045944 | positive regulation of transcription by RNA polymerase II | 20861184 |
Hgene | KMT2A | GO:0051568 | histone H3-K4 methylation | 19556245 |
Hgene | KMT2A | GO:0065003 | protein-containing complex assembly | 15199122 |
Hgene | KMT2A | GO:0080182 | histone H3-K4 trimethylation | 20861184 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | AY125965 | KMT2A | chr11 | 118353213 | + | CBL | chr11 | 119155677 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000534358 | ENST00000264033 | KMT2A | chr11 | 118353213 | + | CBL | chr11 | 119155677 | + |
In-frame | ENST00000389506 | ENST00000264033 | KMT2A | chr11 | 118353213 | + | CBL | chr11 | 119155677 | + |
In-frame | ENST00000354520 | ENST00000264033 | KMT2A | chr11 | 118353213 | + | CBL | chr11 | 119155677 | + |
intron-3CDS | ENST00000420751 | ENST00000264033 | KMT2A | chr11 | 118353213 | + | CBL | chr11 | 119155677 | + |
Top |
FusionProtFeatures for KMT2A_CBL |
![]() |
Hgene | Tgene |
KMT2A | CBL |
Adapter protein that functions as a negative regulatorof many signaling pathways that are triggered by activation ofcell surface receptors. Acts as an E3 ubiquitin-protein ligase,which accepts ubiquitin from specific E2 ubiquitin-conjugatingenzymes, and then transfers it to substrates promoting theirdegradation by the proteasome. Recognizes activated receptortyrosine kinases, including KIT, FLT1, FGFR1, FGFR2, PDGFRA,PDGFRB, EGFR, CSF1R, EPHA8 and KDR and terminates signaling.Recognizes membrane-bound HCK, SRC and other kinases of the SRCfamily and mediates their ubiquitination and degradation.Participates in signal transduction in hematopoietic cells. Playsan important role in the regulation of osteoblast differentiationand apoptosis. Essential for osteoclastic bone resorption. The'Tyr-731' phosphorylated form induces the activation andrecruitment of phosphatidylinositol 3-kinase to the cell membranein a signaling pathway that is critical for osteoclast function.May be functionally coupled with the E2 ubiquitin-protein ligaseUB2D3. {ECO:0000269|PubMed:10514377, ECO:0000269|PubMed:11896602,ECO:0000269|PubMed:14661060, ECO:0000269|PubMed:14739300,ECO:0000269|PubMed:15190072, ECO:0000269|PubMed:17509076,ECO:0000269|PubMed:18374639, ECO:0000269|PubMed:19689429,ECO:0000269|PubMed:21596750}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 137_143 | 1362 | 3932 | Compositional bias | Note=Poly-Gly |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 17_102 | 1362 | 3932 | Compositional bias | Note=Ala/Gly/Ser-rich |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 561_564 | 1362 | 3932 | Compositional bias | Note=Poly-Pro |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 568_571 | 1362 | 3932 | Compositional bias | Note=Poly-Pro |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 137_143 | 1362 | 3970 | Compositional bias | Note=Poly-Gly |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 17_102 | 1362 | 3970 | Compositional bias | Note=Ala/Gly/Ser-rich |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 561_564 | 1362 | 3970 | Compositional bias | Note=Poly-Pro |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 568_571 | 1362 | 3970 | Compositional bias | Note=Poly-Pro |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 137_143 | 1362 | 3973 | Compositional bias | Note=Poly-Gly |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 17_102 | 1362 | 3973 | Compositional bias | Note=Ala/Gly/Ser-rich |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 561_564 | 1362 | 3973 | Compositional bias | Note=Poly-Pro |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 568_571 | 1362 | 3973 | Compositional bias | Note=Poly-Pro |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 169_180 | 1362 | 3932 | DNA binding | Note=A.T hook 1 |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 217_227 | 1362 | 3932 | DNA binding | Note=A.T hook 2 |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 301_309 | 1362 | 3932 | DNA binding | Note=A.T hook 3 |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 169_180 | 1362 | 3970 | DNA binding | Note=A.T hook 1 |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 217_227 | 1362 | 3970 | DNA binding | Note=A.T hook 2 |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 301_309 | 1362 | 3970 | DNA binding | Note=A.T hook 3 |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 169_180 | 1362 | 3973 | DNA binding | Note=A.T hook 1 |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 217_227 | 1362 | 3973 | DNA binding | Note=A.T hook 2 |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 301_309 | 1362 | 3973 | DNA binding | Note=A.T hook 3 |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 1147_1195 | 1362 | 3932 | Zinc finger | CXXC-type |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 1147_1195 | 1362 | 3970 | Zinc finger | CXXC-type |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 1147_1195 | 1362 | 3973 | Zinc finger | CXXC-type |
Tgene | >CBL | chr11:118353213 | chr11:119155677 | ENST00000264033 | + | 8 | 16 | 477_688 | 477 | 907 | Compositional bias | Note=Pro-rich |
Tgene | >CBL | chr11:118353213 | chr11:119155677 | ENST00000264033 | + | 8 | 16 | 689_834 | 477 | 907 | Compositional bias | Note=Asp/Glu-rich (acidic) |
Tgene | >CBL | chr11:118353213 | chr11:119155677 | ENST00000264033 | + | 8 | 16 | 856_895 | 477 | 907 | Domain | UBA |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 1703_1748 | 1362 | 3932 | Domain | Bromo%3B divergent |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 2018_2074 | 1362 | 3932 | Domain | FYR N-terminal |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 3666_3747 | 1362 | 3932 | Domain | FYR C-terminal |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 3829_3945 | 1362 | 3932 | Domain | SET |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 3953_3969 | 1362 | 3932 | Domain | Post-SET |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 1703_1748 | 1362 | 3970 | Domain | Bromo%3B divergent |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 2018_2074 | 1362 | 3970 | Domain | FYR N-terminal |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 3666_3747 | 1362 | 3970 | Domain | FYR C-terminal |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 3829_3945 | 1362 | 3970 | Domain | SET |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 3953_3969 | 1362 | 3970 | Domain | Post-SET |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 1703_1748 | 1362 | 3973 | Domain | Bromo%3B divergent |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 2018_2074 | 1362 | 3973 | Domain | FYR N-terminal |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 3666_3747 | 1362 | 3973 | Domain | FYR C-terminal |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 3829_3945 | 1362 | 3973 | Domain | SET |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 3953_3969 | 1362 | 3973 | Domain | Post-SET |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 3906_3907 | 1362 | 3932 | Region | S-adenosyl-L-methionine binding |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 3906_3907 | 1362 | 3970 | Region | S-adenosyl-L-methionine binding |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 3906_3907 | 1362 | 3973 | Region | S-adenosyl-L-methionine binding |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 1431_1482 | 1362 | 3932 | Zinc finger | PHD-type 1 |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 1479_1533 | 1362 | 3932 | Zinc finger | PHD-type 2 |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 1566_1627 | 1362 | 3932 | Zinc finger | PHD-type 3 |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 1870_1910 | 1362 | 3932 | Zinc finger | C2HC pre-PHD-type |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 1931_1978 | 1362 | 3932 | Zinc finger | PHD-type 4 |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 1431_1482 | 1362 | 3970 | Zinc finger | PHD-type 1 |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 1479_1533 | 1362 | 3970 | Zinc finger | PHD-type 2 |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 1566_1627 | 1362 | 3970 | Zinc finger | PHD-type 3 |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 1870_1910 | 1362 | 3970 | Zinc finger | C2HC pre-PHD-type |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 1931_1978 | 1362 | 3970 | Zinc finger | PHD-type 4 |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 1431_1482 | 1362 | 3973 | Zinc finger | PHD-type 1 |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 1479_1533 | 1362 | 3973 | Zinc finger | PHD-type 2 |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 1566_1627 | 1362 | 3973 | Zinc finger | PHD-type 3 |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 1870_1910 | 1362 | 3973 | Zinc finger | C2HC pre-PHD-type |
Hgene | >KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 1931_1978 | 1362 | 3973 | Zinc finger | PHD-type 4 |
Tgene | CBL | chr11:118353213 | chr11:119155677 | ENST00000264033 | + | 8 | 16 | 227_240 | 477 | 907 | Calcium binding | . |
Tgene | CBL | chr11:118353213 | chr11:119155677 | ENST00000264033 | + | 8 | 16 | 357_476 | 477 | 907 | Compositional bias | Note=Asp/Glu-rich (acidic) |
Tgene | CBL | chr11:118353213 | chr11:119155677 | ENST00000264033 | + | 8 | 16 | 47_351 | 477 | 907 | Domain | Cbl-PTB |
Tgene | CBL | chr11:118353213 | chr11:119155677 | ENST00000264033 | + | 8 | 16 | 176_248 | 477 | 907 | Region | Note=EF-hand-like |
Tgene | CBL | chr11:118353213 | chr11:119155677 | ENST00000264033 | + | 8 | 16 | 249_351 | 477 | 907 | Region | Note=SH2-like |
Tgene | CBL | chr11:118353213 | chr11:119155677 | ENST00000264033 | + | 8 | 16 | 352_380 | 477 | 907 | Region | Note=Linker |
Tgene | CBL | chr11:118353213 | chr11:119155677 | ENST00000264033 | + | 8 | 16 | 47_175 | 477 | 907 | Region | Note=4H |
Tgene | CBL | chr11:118353213 | chr11:119155677 | ENST00000264033 | + | 8 | 16 | 381_420 | 477 | 907 | Zinc finger | RING-type |
Top |
FusionGeneSequence for KMT2A_CBL |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for KMT2A_CBL |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
KMT2A | PPIE, PPP1R15A, KMT2A, ASH2L, HCFC1, HCFC2, MEN1, RBBP5, WDR5, AVP, INS, OXT, MAP3K5, HDAC1, CTBP1, CBX4, BMI1, CREBBP, SMARCB1, CXXC1, MYB, CTNNB1, SNW1, E2F2, E2F4, E2F6, PSIP1, MLLT4, POLR2A, KAT8, RNF2, TP53, SBF1, MTM1, SET, HIST1H3A, HIST1H4A, KAT6A, ELL, AFF1, AFF4, CDK9, CCNT1, CTR9, LEO1, PAF1, CDC73, WDR61, MLLT3, DOT1L, SKP2, HIST3H3, SVIL, HIST2H3C, SIN3A, MLLT1, RUNX1, CBFB, H3F3A, SIRT7, ASB2, TCEB1, TCEB2, CBX8, TOP1, TAF6, NCL, HECW2, LGR4, CSNK2A2, SENP3, SYMPK, PKN1, PIH1D1, KRAS, TAF1, CHD3, SMARCA2, SMARCC2, SMARCC1, HDAC2, RBBP4, RBBP7, TBP, MBD3, SAP30, RAN, TAF9, TASP1, HIST1H2BG, EWSR1, DYNLT1, KIF11, ING4, ZNF131, ASB7 | CBL | KRT18, MYO1C, ZAP70, PDGFRA, CRKL, GRB2, ARHGEF7, HCK, PTK2B, SORBS2, SORBS1, CD2AP, SH2B2, SH3KBP1, PIK3R2, YWHAQ, SLA, SH3BP2, EGFR, PTPN6, LCK, SPRY2, CSF1R, SH3GL3, MET, SYK, FRS2, UBE2L3, BTK, LYN, FYN, TYK2, YWHAB, YWHAZ, VAV1, LCP2, UBE2D2, FGR, ABL1, SLA2, INPPL1, SHC1, NCK1, PLCG1, SH3GL2, FLOT1, PIK3R1, CRK, CSK, ITK, CD5, LTK, IGF1R, PTPN11, UBE2D1, SPRY4, UBC, CBL, CSF1, GAPVD1, KDR, ITSN1, MST1R, UBE2M, AXL, ITGA5, KIT, LRIG1, UBASH3A, UBASH3B, GAPDH, EEF1A1, CDC42, SRC, NOTCH1, CD247, STAP2, TNFRSF10A, TNFRSF10B, FCGR2A, MYH9, ACTA1, ACTB, ACTG2, VIM, HSPA4, HSPA5, EPHA8, UBE4B, EPHB1, IL7R, CD33, NTRK1, CFTR, PSMC5, ITCH, TEK, BAG1, PTK2, PXN, VAV2, IRF8, RET, IRS1, ITSN2, HRAS, DBNL, ASAP1, TNFRSF1A, MAPK14, MAPK8, BLNK, INPP5D, TUBB, TUBA1A, SOS1, NOTCH3, SMAD3, CALM1, YES1, SFN, YWHAH, YWHAE, EPHA2, RAPGEF1, ABI1, GIF, TCN1, TCN2, MYH2, HTR2A, FYB, FGFR2, GBA, SORBS3, ITGAV, BCAR1, CD38, BCR, OSTF1, GRAP2, PIK3CA, CD40, BLK, SYNM, CUBN, SPRY1, LAT, SNX18, KRT10, KRT1, KRT2, HSPA8, PIK3CB, SPTBN1, KRT6C, KRT6B, KRT9, KRT14, KRT5, ACACA, KRT16, TUBB4B, KRT6A, TUBA1C, HSPA9, HSPA1L, MYH10, IQGAP1, KRT17, HSPA1B, SPTA1, SPTAN1, HSPA6, CCT8, KRT79, RPS19, CBLB, KRT84, CORO1C, TRIM21, KRT3, TUBA4B, CAD, ACTN1, POP1, PRKCA, PRKCQ, MAP3K11, EPOR, UBE2D3, TRPV1, USP21, PTPN22, ITGA4, STAT5A, PTEN, TNS4, CTNNB1, WAS, TRAF4, TRIM8, IRF1, FLT3, LOX, NCK2, ERBB2, CAPZA1, PRPSAP2, ERBB4, SIRT2, FRS3, FLT1, TGFBR2, SSFA2, SMAD7, PIK3R3, APPL1, EPS8, STAT3, MZF1, SERPINA5, CEP170, CEP128, FBF1, NPHP1, XPO1, PSMC1, XRCC5, ERBB2IP, SP7, ARHGEF6, TGM2, TSG101, IRF3, CDH1, RAB39B, TRIM25, TRAF2 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Tgene | CBL | chr11:118353213 | chr11:119155677 | ENST00000264033 | + | 8 | 16 | 648_906 | 477 | 907 | CD2AP |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 1584_1600 | 1362 | 3932 | histone H3K4me3 |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 1584_1600 | 1362 | 3970 | histone H3K4me3 |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 1584_1600 | 1362 | 3973 | histone H3K4me3 |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000354520 | + | 8 | 35 | 3764_3771 | 1362 | 3932 | WDR5 |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000389506 | + | 8 | 36 | 3764_3771 | 1362 | 3970 | WDR5 |
Hgene | KMT2A | chr11:118353213 | chr11:119155677 | ENST00000534358 | + | 8 | 36 | 3764_3771 | 1362 | 3973 | WDR5 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for KMT2A_CBL |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for KMT2A_CBL |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | KMT2A | C0023418 | leukemia | 2 | CTD_human |
Hgene | KMT2A | C0023467 | Leukemia, Myelocytic, Acute | 2 | CTD_human |
Hgene | KMT2A | C0023470 | Myeloid Leukemia | 2 | CTD_human |
Hgene | KMT2A | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 2 | CTD_human |
Hgene | KMT2A | C0001418 | Adenocarcinoma | 1 | CTD_human |
Hgene | KMT2A | C0005695 | Bladder Neoplasm | 1 | CTD_human |
Hgene | KMT2A | C0007138 | Carcinoma, Transitional Cell | 1 | CTD_human |
Hgene | KMT2A | C0008625 | Chromosome Aberrations | 1 | CTD_human |
Hgene | KMT2A | C0023448 | Lymphoid leukemia | 1 | CTD_human |
Hgene | KMT2A | C0023465 | Acute monocytic leukemia | 1 | CTD_human |
Hgene | KMT2A | C0023479 | Acute myelomonocytic leukemia | 1 | CTD_human |
Hgene | KMT2A | C0036341 | Schizophrenia | 1 | PSYGENET |
Hgene | KMT2A | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Hgene | KMT2A | C0149925 | Small cell carcinoma of lung | 1 | CTD_human |
Hgene | KMT2A | C2239176 | Liver carcinoma | 1 | CTD_human |
Tgene | CBL | C0349639 | Juvenile Myelomonocytic Leukemia | 3 | CTD_human;HPO;ORPHANET |
Tgene | CBL | C0008073 | Developmental Disabilities | 1 | CTD_human |
Tgene | CBL | C0010417 | Cryptorchidism | 1 | CTD_human;HPO |
Tgene | CBL | C0018273 | Growth Disorders | 1 | CTD_human |
Tgene | CBL | C0042384 | Vasculitis | 1 | CTD_human |
Tgene | CBL | C3150803 | NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA | 1 | CTD_human;ORPHANET;UNIPROT |